PROPRIETARY INNOVATION

Alcohol Reduction on Demand

A patent-pending wearable drug-device platform being developed for rapid alcohol reduction, with an approximately 10-minute development target.

Development targetApproximately 10 minutesStatusPatent pending · InvestigationalDeveloperMinerva Wise Limited
European life-science researcher evaluating a wearable healthcare device

THE PROGRAMME

A regulated healthcare development programme, not a consumer claim.

Minerva Wise Limited is developing a wearable drug-device platform intended to support rapid alcohol reduction after an adult decides that drinking has finished.

The programme remains investigational. Its performance, safety, efficacy and regulatory status must be established through the planned scientific and product-development programme.

The current approximately 10-minute timeframe is a development target. It is not a demonstrated clinical outcome or an approved claim.

Confidential technical architecture, unpublished mechanisms and experimental parameters are not disclosed publicly. Nothing on this page constitutes a claim of safety, efficacy or regulatory approval.

DEVELOPMENT APPROACH

Building a regulated healthcare innovation requires much more than an idea.

It requires coordinated progress across intellectual property, science, specialist suppliers, regulatory strategy, product development and the expertise required at each stage.

01

Intellectual Property

Protectable concepts, patent strategy and controlled technical disclosure.

02

Scientific Development

Evidence generation and structured scientific validation appropriate to the programme stage.

03

Product Development

Drug-device integration, development planning, specialist suppliers and industrial coordination.

04

Regulatory Strategy

Regulatory pathway assessment and documentation planning for a regulated combination-product programme.

05

International Development

Strategic, industrial and market-development coordination across international partners.

06

Commercialisation Pathway

Preparation for validation, manufacturing, regulatory progression and eventual market introduction.

STRATEGIC PARTNERSHIPS

Strategic partnerships

Minerva Wise is currently engaging with selected strategic, scientific and development partners for the next stages of the programme.

The programme presentation is available below for strategic, scientific, development, industrial and selected investment enquiries.

Alcohol Reduction Drug-Device Platform PresentationAlcohol Reduction Drug-Device Platform Presentation

MINERVA WISE LIMITED

International healthcare development and proprietary innovation.

For strategic, scientific, development or commercial enquiries relating to this programme, contact Minerva Wise Limited.

Contact Minerva Wise